Pfizer Looks At India For New Growth Avenues To Accelerate Innovation
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Pfizer's keenness to strike partnership deals for research in India is growing. At a conference called "Pfizer Partnership Summit" held Jan. 31 in Hyderabad, Pfizer's global research and development head Martin Mackay indicated his intention to work closely with Indian companies on new drug innovation